TSH Levels in Pregnancy: What Is Normal and Why It Matters

Why does pregnancy change what TSH levels should be?

Pregnancy causes profound changes in thyroid physiology. In the first trimester, rising human chorionic gonadotropin (hCG) — the same hormone detected by a pregnancy test — stimulates the thyroid receptors (because hCG and TSH share structural similarity), causing TSH to fall naturally. Thyroid hormone production also increases by about 50% to meet the demands of the growing fetus, which cannot produce its own thyroid hormones until the second trimester 1Ref 1Korevaar TIM, Leung AM, Alexander EK, Bliddal S, Boelaert K, Brenta G, et al. (2026).American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum.Trimester-specific TSH targets in pregnancy; levothyroxine dose adjustment guidance; subclinical hypothyroidism treatment thresholds; management of antibody-positive patients; postpartum monitoring.

As a result, the TSH reference range is lower during pregnancy than outside of it, particularly in the first trimester. Using non-pregnant reference ranges can misclassify normal pregnant patients as hyperthyroid or miss true hypothyroidism 2Ref 2Alexander EK, Pearce EN, Brent GA, et al. (2017).2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum.Foundational ATA pregnancy thyroid guidelines establishing trimester-specific TSH reference ranges; levothyroxine dose increase recommendations; monitoring frequency during each trimester.

What are the target TSH ranges during pregnancy?

The ATA recommends using population- and trimester-specific TSH reference intervals whenever possible 1Ref 1Korevaar TIM, Leung AM, Alexander EK, Bliddal S, Boelaert K, Brenta G, et al. (2026).American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum.Trimester-specific TSH targets in pregnancy; levothyroxine dose adjustment guidance; subclinical hypothyroidism treatment thresholds; management of antibody-positive patients; postpartum monitoring2Ref 2Alexander EK, Pearce EN, Brent GA, et al. (2017).2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum.Foundational ATA pregnancy thyroid guidelines establishing trimester-specific TSH reference ranges; levothyroxine dose increase recommendations; monitoring frequency during each trimester. When lab-specific ranges are unavailable, commonly used general targets are:

| Trimester | TSH target range | |---|---| | First (weeks 1–12) | 0.1 – 2.5 mIU/L | | Second (weeks 13–26) | 0.2 – 3.0 mIU/L | | Third (weeks 27–40) | 0.3 – 3.0 mIU/L |

These are guidelines, not absolute cutoffs. Your care team will interpret your individual result in the context of your lab's reference range, your symptoms, and whether you are on thyroid medication. The 2026 ATA guidelines emphasize using institution-specific ranges when available rather than fixed universal thresholds 1Ref 1Korevaar TIM, Leung AM, Alexander EK, Bliddal S, Boelaert K, Brenta G, et al. (2026).American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum.Trimester-specific TSH targets in pregnancy; levothyroxine dose adjustment guidance; subclinical hypothyroidism treatment thresholds; management of antibody-positive patients; postpartum monitoring.

Why does levothyroxine dose need to increase in pregnancy?

Women already taking levothyroxine (for hypothyroidism or after thyroid surgery) typically need a higher dose during pregnancy. This is because: - Thyroid hormone demand increases by approximately 30–50% to support fetal brain and nervous system development 2Ref 2Alexander EK, Pearce EN, Brent GA, et al. (2017).2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum.Foundational ATA pregnancy thyroid guidelines establishing trimester-specific TSH reference ranges; levothyroxine dose increase recommendations; monitoring frequency during each trimester - Estrogen raises thyroid-binding globulin (TBG), which binds more T4, lowering the free T4 available to tissues 1Ref 1Korevaar TIM, Leung AM, Alexander EK, Bliddal S, Boelaert K, Brenta G, et al. (2026).American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum.Trimester-specific TSH targets in pregnancy; levothyroxine dose adjustment guidance; subclinical hypothyroidism treatment thresholds; management of antibody-positive patients; postpartum monitoring - Gastrointestinal absorption of levothyroxine may change during pregnancy

The general principles of levothyroxine dosing are grounded in thyroid hormone replacement guidelines 3Ref 3Jonklaas J, Bianco AC, Bauer AJ, et al. (2014).Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement.Background on levothyroxine dosing and thyroid hormone replacement principles; subclinical hypothyroidism treatment considerations. Many clinicians advise women with hypothyroidism to call their OB or endocrinologist immediately upon a positive pregnancy test so the dose can be increased preemptively — often by taking two extra doses per week of the current prescription 2Ref 2Alexander EK, Pearce EN, Brent GA, et al. (2017).2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum.Foundational ATA pregnancy thyroid guidelines establishing trimester-specific TSH reference ranges; levothyroxine dose increase recommendations; monitoring frequency during each trimester. TSH should be checked every 4–6 weeks through the first half of pregnancy 1Ref 1Korevaar TIM, Leung AM, Alexander EK, Bliddal S, Boelaert K, Brenta G, et al. (2026).American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum.Trimester-specific TSH targets in pregnancy; levothyroxine dose adjustment guidance; subclinical hypothyroidism treatment thresholds; management of antibody-positive patients; postpartum monitoring.

What is subclinical hypothyroidism in pregnancy, and does it need treatment?

Subclinical hypothyroidism is defined as a TSH above the trimester-specific upper limit with a normal free T4. Whether and when to treat it during pregnancy is nuanced 1Ref 1Korevaar TIM, Leung AM, Alexander EK, Bliddal S, Boelaert K, Brenta G, et al. (2026).American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum.Trimester-specific TSH targets in pregnancy; levothyroxine dose adjustment guidance; subclinical hypothyroidism treatment thresholds; management of antibody-positive patients; postpartum monitoring2Ref 2Alexander EK, Pearce EN, Brent GA, et al. (2017).2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum.Foundational ATA pregnancy thyroid guidelines establishing trimester-specific TSH reference ranges; levothyroxine dose increase recommendations; monitoring frequency during each trimester:

• Antibody-positive patients (thyroid peroxidase antibodies, TPO-Ab positive) with subclinical hypothyroidism are generally treated with levothyroxine, because these patients have higher rates of pregnancy complications and progression to overt hypothyroidism
• Antibody-negative patients with TSH modestly above range may be managed with treatment or close monitoring, depending on the degree of TSH elevation and clinical context
• Overt hypothyroidism (elevated TSH with low free T4) is always treated in pregnancy, as uncontrolled hypothyroidism is associated with adverse fetal neurodevelopmental outcomes

This is an active area of guideline evolution — the 2026 ATA guidelines provide updated thresholds 1Ref 1Korevaar TIM, Leung AM, Alexander EK, Bliddal S, Boelaert K, Brenta G, et al. (2026).American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum.Trimester-specific TSH targets in pregnancy; levothyroxine dose adjustment guidance; subclinical hypothyroidism treatment thresholds; management of antibody-positive patients; postpartum monitoring.

What about women with thyroid antibodies but normal TSH?

Women who are TPO-antibody positive but have a normal TSH before pregnancy represent an important group. Evidence suggests they are at higher risk of hypothyroidism during pregnancy and postpartum thyroiditis afterward 4Ref 4Weetman AP (2021).An update on the pathogenesis of Hashimoto's thyroiditis.Postpartum thyroiditis as a distinct autoimmune thyroid flare relevant to women with Hashimoto's thyroiditis after delivery; antibody-positive patients at elevated risk. Most guidelines recommend more frequent TSH monitoring (every 4 weeks in the first trimester, then once in mid-pregnancy) for this group 1Ref 1Korevaar TIM, Leung AM, Alexander EK, Bliddal S, Boelaert K, Brenta G, et al. (2026).American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum.Trimester-specific TSH targets in pregnancy; levothyroxine dose adjustment guidance; subclinical hypothyroidism treatment thresholds; management of antibody-positive patients; postpartum monitoring2Ref 2Alexander EK, Pearce EN, Brent GA, et al. (2017).2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum.Foundational ATA pregnancy thyroid guidelines establishing trimester-specific TSH reference ranges; levothyroxine dose increase recommendations; monitoring frequency during each trimester. Some clinicians initiate low-dose levothyroxine preventively in antibody-positive patients with TSH above 2.5 mIU/L, though evidence on this approach is evolving.

What happens to levothyroxine dose after delivery?

After delivery, thyroid hormone demands return to pre-pregnancy levels. Women on levothyroxine usually need to return to their pre-pregnancy dose immediately after delivery, and TSH should be rechecked at 6–8 weeks postpartum 1Ref 1Korevaar TIM, Leung AM, Alexander EK, Bliddal S, Boelaert K, Brenta G, et al. (2026).American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum.Trimester-specific TSH targets in pregnancy; levothyroxine dose adjustment guidance; subclinical hypothyroidism treatment thresholds; management of antibody-positive patients; postpartum monitoring.

Women with autoimmune thyroid disease (particularly Hashimoto's thyroiditis, indicated by TPO antibodies) are at elevated risk for postpartum thyroiditis — an autoimmune flare that can cause a brief hyperthyroid phase followed by hypothyroidism in the months after delivery 4Ref 4Weetman AP (2021).An update on the pathogenesis of Hashimoto's thyroiditis.Postpartum thyroiditis as a distinct autoimmune thyroid flare relevant to women with Hashimoto's thyroiditis after delivery; antibody-positive patients at elevated risk. Symptoms can overlap with postpartum depression and fatigue, making thyroid testing useful in that clinical context.

How Gale can help

If you are pregnant or planning a pregnancy and have a thyroid condition, a Gale clinician can help you understand your thyroid results, review whether your current management is consistent with pregnancy guidelines, and coordinate with your obstetrician or endocrinologist. For newly pregnant women with no known thyroid history who have symptoms of hypothyroidism, connecting with a clinician early is the most important step.